Biotech Calendar: Upcoming FDA Dates
A quick and dirty guide to the expected regulatory news from the FDA through June 2010.
04:25PM 12/14/09
Human Genome's CEO: Biotech's Best '09
Human Genome Science's CEO Thomas Watkins is Adam Feuerstein's Best Biotech CEO of the Year for 2009.
11:50AM 12/14/09
Small-Caps, Breadth Hold Their Ground (RealMoney.com $)
What we're seeing is group rotation with small-caps leading the way amid better breadth.
08:00AM 12/07/09
10:30AM 12/03/09
08:30AM 12/01/09
This Isn't 2003 (RealMoney.com $)
You need to look beyond the chart of the S&P to see the real story.
07:07AM 11/27/09
The Lupus Foundation Of America Hosts Special Webinar To Discuss BENLYSTA(TM) Results
01:07PM 11/25/09
Human Genome Sciences Seeks Approval For Zalbin
Human Genome Sciences says it filed application for hepatitis C drug candidate Zalbin
11:48AM 11/25/09
09:53AM 11/23/09
Human Genome Sees FDA Delay With Anthrax Treatment
Human Genome Sciences faces FDA regulatory delay on anthrax treatment
11:17AM 11/16/09
Doc Offers Top Hep C Drug Picks: BioBuzz
Vertex, InterMune, Pharmasset get positive reviews after recent Hep C meeting.
01:54PM 11/09/09
'Mad Money Lightning Round': Stick With Goldman Sachs
Cramer says investors should hold onto the stock for the long term.
07:15PM 11/04/09
Cramer's 'Mad Money' Recap: The Bears' Negative Script (Final)
Cramer says the bears' pessimistic message has cost investors a fortune in the market. Click for news from Jim Cramer.
06:28PM 11/04/09
Biotech Calendar: Key Dates for November
Your quick-and-dirty guide to key dates and events for biotech investors during November.
07:12AM 11/02/09



Connect with TheStreet